 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 November 1997 | Volume 127 Issue 9 | Pages 788-795
Background: The benefits of intensive glycemic control in patients with type 2 diabetes are not well quantified. It is therefore not clear which patients will benefit most from aggressive glycemic control.
Objective: To evaluate the efficacy of glycemic control in type 2 diabetes.
Design: Markov decision model.
Patients: Diabetic patients at a health maintenance organization.
Main Outcome Measures: Risks for developing blindness and end-stage renal disease; number of patients and patient-years needed to treat to prevent complications.
Results: For a patient in whom diabetes developed before 50 years of age, reducing hemoglobin A1c levels from 9% to 7% results in an estimated 2.3-percentage point decrease (from 2.6% to 0.3%) in lifetime risk for blindness due to retinopathy. The same change in a patient with diabetes onset at 65 years of age would be expected to decrease the risk for blindness by 0.5 percentage points (from 0.5% to <0.1%). However, the Markov model predicts substantially greater benefit when moving from poor to moderate glycemic control than when moving from moderate to almost-normal glycemic control. Targeting less than 20% of the patients at one health maintenance organization for intensified therapy may prevent more than 80% of the preventable patient-time spent blind. The risks for end-stage renal disease and the risk reduction provided by improved glycemic control are lower than those for blindness.
Conclusions: This probability model, based on extrapolation from the experience with type 1 diabetes, suggests that patients with early onset of type 2 diabetes will accrue substantial benefit from almost-normal glycemic control. In patients with later onset, moderate glycemic control prevents most end-stage complications caused by microvascular disease. These results have important implications for informing patients and allocating health care resources.
Author and Article Information
From the Veterans Affairs Center for Practice Management and Outcomes Research and the University of Michigan School of Medicine, Ann Arbor, Michigan.
ARTICLE
Estimated Benefits of Glycemic Control in Microvascular Complications in Type 2 Diabetes
Grant Support: In part by grant HSO 6665-01 from the Agency for Health Care Policy and Research. Dr. Vijan is an Agency for Health Care Policy and Research Health Services Research Fellow, and Dr. Hofer is a Veterans Affairs Health Services Research and Development Career Development Awardee.
Requests for Reprints: Sandeep Vijan, MD, Veterans Affairs Health Services Research and Development, PO Box 130170, Ann Arbor, MI 48113-0170.
Current Author Addresses: Drs. Vijan, Hofer, and Hayward: Veterans Affairs Health Services Research and Development, PO Box 130170, Ann Arbor, MI 48113-0170.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  E. S. Huang, Q. Zhang, N. Gandra, M. H. Chin, and D. O. Meltzer The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis Ann Intern Med, July 1, 2008; 149(1): 11 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rizza, D. Eddy, and R. Kahn Cure, Care, and Commitment: What Can We Look Forward To? Diabetes Care, May 1, 2008; 31(5): 1051 - 1059. [Full Text] [PDF]
|
|
|
|
 |
|
 L. McAndrew, S. H. Schneider, E. Burns, and H. Leventhal Does Patient Blood Glucose Monitoring Improve Diabetes Control?: A Systematic Review of the Literature The Diabetes Educator, November 1, 2007; 33(6): 991 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Heisler, J. D. Faul, R. A. Hayward, K. M. Langa, C. Blaum, and D. Weir Mechanisms for Racial and Ethnic Disparities in Glycemic Control in Middle-aged and Older Americans in the Health and Retirement Study Arch Intern Med, September 24, 2007; 167(17): 1853 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bolen, L. Feldman, J. Vassy, L. Wilson, H.-C. Yeh, S. Marinopoulos, C. Wiley, E. Selvin, R. Wilson, E. B. Bass, et al. Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus Ann Intern Med, September 18, 2007; 147(6): 386 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hayward, T. P. Hofer, and S. Vijan Intensive Glucose Control in Elderly Adults JAMA, May 23, 2007; 297(20): 2195 - 2195. [Full Text] [PDF]
|
|
|
|
|
|
L. Pogach, M. Engelgau, and D. Aron Measuring Progress Toward Achieving Hemoglobin A1c Goals in Diabetes Care: Pass/Fail or Partial Credit JAMA, February 7, 2007; 297(5): 520 - 523. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Aron, M. Rajan, and L. M. Pogach Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds Int. J. Qual. Health Care, February 1, 2007; 19(1): 29 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Gagliardino, M. d. C. Malbran, and C. Clark Jr. Development and Implementation of Advanced Training Course for Diabetes Educators in Argentina Diabetes Spectr, January 1, 2007; 20(1): 24 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hayward, T. P. Hofer, and S. Vijan Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med, October 3, 2006; 145(7): 520 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Sinclair Special Considerations in Older Adults With Diabetes: Meeting the Challenge Diabetes Spectr, October 1, 2006; 19(4): 229 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Pogach, M. Rajan, and D. C. Aron Comparison of Weighted Performance Measurement and Dichotomous Thresholds for Glycemic Control in the Veterans Health Administration Diabetes Care, February 1, 2006; 29(2): 241 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Huang, M. Shook, L. Jin, M. H. Chin, and D. O. Meltzer The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes Diabetes Care, February 1, 2006; 29(2): 259 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Consensus Panel Guidelines for Computer Modeling of Diabetes and Its Complications Diabetes Care, September 1, 2004; 27(9): 2262 - 2265. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Hoerger, R. Harris, K. A. Hicks, K. Donahue, S. Sorensen, and M. Engelgau Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis Ann Intern Med, May 4, 2004; 140(9): 689 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hayward, T. P. Hofer, E. A. Kerr, and S. L. Krein Quality Improvement Initiatives: Issues in moving from diabetes guidelines to policy Diabetes Care, May 1, 2004; 27(suppl_2): B54 - B60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Pogach, S. A. Brietzke, C. L. Cowan Jr., P. Conlin, D. J. Walder, and C. T. Sawin Development of Evidence-Based Clinical Practice Guidelines for Diabetes: The Department of Veterans Affairs/Department of Defense Guidelines Initiative Diabetes Care, May 1, 2004; 27(suppl_2): B82 - B89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rowe, C. H. MacLean, and P. G. Shekelle Preventing Visual Loss From Chronic Eye Disease in Primary Care: Scientific Review JAMA, March 24, 2004; 291(12): 1487 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Eddy and L. Schlessinger Archimedes: A trial-validated model of diabetes Diabetes Care, November 1, 2003; 26(11): 3093 - 3101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn Dealing With Complexity in Clinical Diabetes: The value of Archimedes Diabetes Care, November 1, 2003; 26(11): 3168 - 3171. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Abraira and W. Duckworth The Need for Glycemic Trials in Type 2 Diabetes Clin. Diabetes, July 1, 2003; 21(3): 107 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. V. Pugh, J. Anderson, L. M. Pogach, and D. R. Berlowitz Differential Adoption of Pharmacotherapy Recommendations for Type 2 Diabetes by Generalists and Specialists Med Care Res Rev, June 1, 2003; 60(2): 178 - 200. [Abstract] [PDF]
|
|
|
|
|
|
S. Vijan and R. A. Hayward Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med, April 1, 2003; 138(7): 593 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Saydah, M. S. Eberhardt, C. M. Loria, and F. L. Brancati Age and the Burden of Death Attributable to Diabetes in the United States Am. J. Epidemiol., October 15, 2002; 156(8): 714 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Raji, H. Gomes, J. O. Beard, P. MacDonald, and P. R. Conlin A Randomized Trial Comparing Intensive and Passive Education in Patients With Diabetes Mellitus Arch Intern Med, June 10, 2002; 162(11): 1301 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Langa, S. Vijan, R. A. Hayward, M. E. Chernew, C. S. Blaum, M. U. Kabeto, D. R. Weir, S. J. Katz, R. J. Willis, and A. M. Fendrick Informal Caregiving for Diabetes and Diabetic Complications Among Elderly Americans J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2002; 57(3): S177 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Golin, M. DIMatteo, B. Leaks, N. Duan, and L. Gelberg A Diabetes-Specific Measure of Patient Desire to Participate in Medical Decision Making The Diabetes Educator, November 1, 2001; 27(6): 875 - 886. [Abstract] [PDF]
|
|
|
|
|
|
B. B. Fleming, S. Greenfield, M. M. Engelgau, L. M. Pogach, S. B. Clauser, and M. A. Parrott The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic Diabetes Care, October 1, 2001; 24(10): 1815 - 1820. [Full Text] [PDF]
|
|
|
|
|
|
J. J. Gagliardino and G. Etchegoyen A Model Educational Program for People With Type 2 Diabetes: A cooperative Latin American implementation study (PEDNID-LA) Diabetes Care, June 1, 2001; 24(6): 1001 - 1007. [Abstract] [Full Text]
|
|
|
|
|
|
W. C. Duckworth, M. McCarren, and C. Abraira Glucose Control and Cardiovascular Complications: The VA Diabetes Trial Diabetes Care, May 1, 2001; 24(5): 942 - 945. [Full Text]
|
|
|
|
 |
|
 G. S. Meneilly and D. Tessier Diabetes in Elderly Adults J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 5M - 13. [Abstract] [Full Text]
|
|
|
|
|
|
M. H. Chin, A. W. Su, L. Jin, and M. P. Nerney Variations in the Care of Elderly Persons With Diabetes Among Endocrinologists, General Internists, and Geriatricians J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2000; 55(10): 601M - 606. [Abstract] [Full Text]
|
|
|
|
|
|
A. R. Williamson, A. E. Hunt, J. F. Pope, and N. M. Tolman Recommendations of Dietitians for Overcoming Barriers to Dietary Adherence in Individuals With Diabetes The Diabetes Educator, March 1, 2000; 26(2): 272 - 279. [Abstract] [PDF]
|
|
|
|
|
|
S. Vijan, T. P. Hofer, and R. A. Hayward Cost-Utility Analysis of Screening Intervals for Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus JAMA, February 16, 2000; 283(7): 889 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dalewitz, N. Khan, and C. O. Hershey Barriers to Control of Blood Glucose in Diabetes Mellitus American Journal of Medical Quality, January 1, 2000; 15(1): 16 - 25. [Abstract] [PDF]
|
|
|
|
|
|
M. C. Riddle, D. M. Karl, J. M. Poothullil, M. J. Lenhard, I. B. Hirsch, T. C. Evans, B. Gaster, P. V. M. Cromme, J. C. Shipp, L. Jovanovic, et al. Insulin Treatment for Type 2 Diabetes JAMA, May 20, 1998; 279(19): 1523 - 1526. [Full Text] [PDF]
|
|
|
|
 |
|
 TIGHT CONTROL FOR TYPE 2 DIABETES? Journal Watch (General), November 14, 1997; 1997(1114): 2 - 2. [Full Text]
|
|
Article
